Groupe LAPHAL

LAPHAL INDUSTRIES is a key player in pharmaceutical contract manufacturing and distribution, specializing in medicines and food supplements. Established in the early 1970s, LAPHAL leverages advanced high-tech investments and a skilled team to offer highly technical and reactive pharmaceutical subcontracting services. In 2020, the company achieved a turnover of 37 million euros with 240 employees across three sites. Its production facilities in Allauch handle liquid and pasty forms, producing 15 million vials, 150 million ampoules, and 15 million suppositories/ovules. The Rousset site specializes in dry forms, with capacities for 750 million uncoated tablets, 550 million coated tablets, 125 million capsules, 50 million blisters, and 5 million pillboxes. Additionally, Laboratoires Pasquier (Domazan), acquired in 2015, contributes 200 million ampoules, 5 million vials, and 5 million Flackpull. LAPHAL provides comprehensive industrial services including galenic development, pilot and trial batches, and marketing authorization application drafting. It also offers analytical services such as analytical development and validation, ICH-compliant stability studies, and physico-chemical and microbiological analyses. The company's robust logistics capabilities ensure efficient distribution across France and internationally to wholesalers, pharmacies, hospitals, medical representatives, and pharmaceutical delegates.